Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Choueiri, Toni
Item TypeName
Academic Article Recent advances in the systemic treatment of metastatic papillary renal cancer.
Academic Article Severe pazopanib-induced hepatotoxicity: clinical and histologic course in two patients.
Academic Article Hematologic toxicities in cancer patients treated with the multi-tyrosine kinase sorafenib: a meta-analysis of clinical trials.
Academic Article Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions.
Academic Article Risk of arterial thromboembolic events with sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials.
Academic Article Double-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancer.
Academic Article Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the international kidney cancer working group.
Academic Article Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma.
Academic Article The double edged sword of bleeding and clotting from VEGF inhibition in renal cancer patients.
Academic Article Sequencing of agents for metastatic renal cell carcinoma: can we customize therapy?
Academic Article Meta-analysis of randomized controlled trials for the incidence and risk of treatment-related mortality in patients with cancer treated with vascular endothelial growth factor tyrosine kinase inhibitors.
Academic Article Predicting outcome to VEGF-targeted therapy in metastatic clear-cell renal cell carcinoma: data from recent studies.
Academic Article ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease.
Concept Protein Kinase Inhibitors
Academic Article Incidence and risk of treatment-related mortality in cancer patients treated with the mammalian target of rapamycin inhibitors.
Academic Article Risk of infections in renal cell carcinoma (RCC) and non-RCC patients treated with mammalian target of rapamycin inhibitors.
Academic Article Venous thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis of randomized clinical trials.
Academic Article Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium.
Academic Article Kidney cancer, version 2.2014.
Academic Article A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy.
Academic Article Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysis.
Academic Article Efficacy of targeted therapy for metastatic renal cell carcinoma in the elderly patient population.
Academic Article First-line Mammalian target of rapamycin inhibition in metastatic renal cell carcinoma: an analysis of practice patterns from the International Metastatic Renal Cell Carcinoma Database Consortium.
Academic Article Hepatotoxicity with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis of randomized clinical trials.
Academic Article Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Academic Article Fatigue with vascular endothelial growth factor receptor tyrosine kinase inhibitors and mammalian target of rapamycin inhibitors in patients with renal cell carcinoma (RCC) and other malignancies: A meta-analysis of randomized clinical trials.
Academic Article Pancreatitis with vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Academic Article A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer.
Academic Article Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study.
Academic Article QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Academic Article Kidney cancer, version 3.2015.
Academic Article Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma.
Academic Article Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma.
Academic Article First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Academic Article Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category.
Academic Article Prognostic Significance of Increases in Hemoglobin in Renal Cell Carcinoma Patients During Treatment With VEGF-directed Therapy.
Academic Article Systemic Therapy for Metastatic Renal-Cell Carcinoma.
Academic Article Proton Pump Inhibitors and Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma.
Academic Article Recommendations for the Management of Rare Kidney Cancers.
Academic Article Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma.
Academic Article Risk Factors for New Hypothyroidism During Tyrosine Kinase Inhibitor Therapy in Advanced Nonthyroidal Cancer Patients.
Academic Article Hypothyroidism During Tyrosine Kinase Inhibitor Therapy Is Associated with Longer Survival in Patients with Advanced Nonthyroidal Cancers.
Academic Article Mechanisms of acquired resistance to rapalogs in metastatic renal cell carcinoma.
Academic Article Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Academic Article Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted Therapies.
Academic Article Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
Academic Article Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders.
Academic Article Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.
Academic Article Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Search Criteria
  • Protein Kinase Inhibitors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.